|
|
||||||||
The Journal of Immunology, Vol 143, Issue 11 3503-3511, Copyright © 1989 by American Association of Immunologists
ARTICLES |
M Sykes, CH Chester, TM Sundt, ML Romick, KA Hoyles and DH Sachs
Transplantation Biology Section, National Cancer Institute, Bethesda, MD 20892.
The opposing problems of graft-vs-host disease vs failure of alloengraftment severely limit the success of allogeneic bone marrow transplantation as a therapeutic modality. We have recently used a murine bone marrow transplantation model involving reconstitution of lethally irradiated mice with mixtures of allogeneic and syngeneic marrow to demonstrate that an allogeneic bone marrow subpopulation, removed by T cell depletion with rabbit anti-mouse brain serum and complement (RAMB/C), is capable of increasing levels of allogeneic chimerism. This effect was observed in an F1 into parent genetic combination lacking the potential for graft-vs-host disease, and radiation protection studies suggested that it was not due to depletion of stem cells by RAMB/C. We have now attempted to characterize the cell population responsible for increasing allogeneic chimerism in this model. The results indicate that neither mature T cells nor NK cells are responsible for this activity. However, an assay involving mixed marrow reconstitution in an Ly-5 congenic strain combination was found to be more sensitive to small degrees of stem cell depletion than radiation protection assays using three-fold titrations of bone marrow cells. Using this assay, we were able to detect some degree of stem cell depletion by treatment with RAMB/C, but not with anti-T cell mAb. Nevertheless, if the effects of alloresistance observed in this model are considered, the degree of stem cell depletion detected by such mixing studies in insufficient to account for the effects of RAMB/C depletion on levels of allogeneic chimerism, suggesting that another cell population with this property remains to be identified.
This article has been cited by other articles:
![]() |
H. Xu, B. G. Exner, P. M. Chilton, C. Schanie, and S. T. Ildstad CD45 Congenic Bone Marrow Transplantation: Evidence for T Cell-Mediated Immunity Stem Cells, November 1, 2004; 22(6): 1039 - 1048. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. van Os, G. de Haan, H. Ito, and M. Sykes The balance among immune suppression, stem cell ablation, competition, and engraftment Blood, April 1, 2004; 103(7): 2859 - 2859. [Full Text] [PDF] |
||||
![]() |
H. Ito, Y. Takeuchi, J. Shaffer, and M. Sykes Local irradiation enhances congenic donor pluripotent hematopoietic stem cell engraftment similarly in irradiated and nonirradiated sites Blood, March 1, 2004; 103(5): 1949 - 1954. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Y. Mapara, Y.-M. Kim, S.-P. Wang, R. Bronson, D. H. Sachs, and M. Sykes Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen-presenting cells Blood, August 13, 2002; 100(5): 1903 - 1909. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. van Os, T. M. Sheridan, S. Robinson, D. Drukteinis, J. L.M. Ferrara, and P. M. Mauch Immunogenicity of Ly5 (CD45)-Antigens Hampers Long-Term Engraftment Following Minimal Conditioning in a Murine Bone Marrow Transplantation Model Stem Cells, January 1, 2001; 19(1): 80 - 87. [Abstract] [Full Text] |
||||
![]() |
D. C. Matthews, P. J. Martin, C. Nourigat, F. R. Appelbaum, D. R. Fisher, and I. D. Bernstein Marrow Ablative and Immunosuppressive Effects of 131I-Anti-CD45 Antibody in Congenic and H2-Mismatched Murine Transplant Models Blood, January 15, 1999; 93(2): 737 - 745. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |